ObsEva's Series A Round

ObsEva raised a round of funding on August 29, 2013.

ObsEva is a Swiss-based, speciality biopharmaceutical company dedicated to the development of drugs for women's reproductive medicine. ObsEva's main focus is on therapies for preterm labor.…

Articles about ObsEva's Series A Round: